Omada Health (OMDA) Stock Forecast, Price Target & Predictions
OMDA Stock Forecast
Omada Health (OMDA) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $23.60, with a high of $30.00 and a low of $18.00. This represents a 3.28% increase from the last price of $22.85.
OMDA Stock Rating
Omada Health stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (90.00%), 1 Hold (10.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
OMDA Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | Omada Health | 3.28% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Healthcare Information Services Stocks | 9.09% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 5 | 12 |
| Avg Price Target | $30.00 | $21.40 | $23.67 |
| Last Closing Price | $22.85 | $22.85 | $22.85 |
| Upside/Downside | 31.29% | -6.35% | 3.59% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Jul, 26 | 5 | 5 | 2 | - | - | 12 |
| Jun, 26 | 5 | 5 | 2 | - | - | 12 |
| May, 26 | 5 | 5 | 2 | - | - | 12 |
| Apr, 26 | 4 | 5 | 2 | - | - | 11 |
| Mar, 26 | 4 | 5 | 2 | - | - | 11 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Craig Hettenbach | Morgan Stanley | $30.00 | $18.08 | 65.93% | 31.29% |
| May 08, 2026 | Evercore ISI | $20.00 | $15.48 | 29.20% | -12.47% | |
| May 08, 2026 | Wells Fargo | $18.00 | $16.40 | 9.76% | -21.23% | |
| May 08, 2026 | Canaccord Genuity | $24.00 | $16.40 | 46.34% | 5.03% | |
| Apr 08, 2026 | Elizabeth Anderson | Evercore ISI | $15.00 | $12.53 | 19.71% | -34.35% |
| Jan 16, 2026 | David Roman | Goldman Sachs | $26.00 | $15.65 | 66.13% | 13.79% |
| Jan 09, 2026 | Goldman Sachs | $29.00 | $16.44 | 76.40% | 26.91% | |
| Jan 08, 2026 | Wells Fargo | $17.00 | $16.44 | 3.41% | -25.60% | |
| Jan 05, 2026 | Saket Kalia | Barclays | $22.00 | $14.90 | 47.65% | -3.72% |
| Dec 18, 2025 | Morgan Stanley | $32.00 | $14.62 | 118.88% | 40.04% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Jun 22, 2026 | Morgan Stanley | Overweight | Overweight | hold |
| May 08, 2026 | Goldman Sachs | Buy | Buy | hold |
| May 08, 2026 | Evercore ISI | Outperform | Outperform | hold |
| May 08, 2026 | Citigroup | Outperform | Outperform | hold |
| Apr 14, 2026 | Citigroup | Outperform | initialise | |
| Apr 08, 2026 | Evercore ISI | Outperform | Outperform | hold |
| Jan 16, 2026 | Goldman Sachs | Buy | Buy | hold |
| Jan 05, 2026 | Barclays | Overweight | Overweight | hold |
| Oct 22, 2025 | Barclays | Overweight | Overweight | hold |
| Jul 01, 2025 | Needham | Buy | initialise |
Financial Forecast
EPS Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-0.85 | $-0.22 | - | - |
| Avg Forecast | $-4.76 | $-0.38 | $-0.13 | $0.08 |
| High Forecast | $-4.68 | $-0.38 | $-0.11 | $0.44 |
| Low Forecast | $-4.81 | $-0.38 | $-0.15 | $-0.12 |
| Surprise % | -82.14% | -42.11% | - | - |
Revenue Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $169.80M | $260.21M | - | - |
| Avg Forecast | $189.67M | $238.91M | $266.36M | $343.97M |
| High Forecast | $191.35M | $240.90M | $266.39M | $347.03M |
| Low Forecast | $187.40M | $236.00M | $266.32M | $339.85M |
| Surprise % | -10.48% | 8.91% | - | - |
Net Income Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-47.14M | $-12.78M | - | - |
| Avg Forecast | $-264.62M | $-21.29M | $-7.25M | $-756.24K |
| High Forecast | $-261.02M | $-21.18M | $-6.13M | $24.73M |
| Low Forecast | $-268.21M | $-21.40M | $-8.36M | $-6.69M |
| Surprise % | -82.19% | -39.99% | - | - |